A follow-up study on visual display terminal use and dry eye disease in the Beijing Adult Dry Eye Cohort Study (ADEC) [0.03%]
北京成人干眼队列研究（ADEC）视觉显示终端使用与干眼病的后续研究
Jiayang Tang,Jun Feng,Kai Cao et al.
Jiayang Tang et al.
Objective: To investigate the association between visual display terminal (VDT) usage frequency and the prevalence of dry eye disease (DED), ocular surface signs, and their trends over a 1-year follow-up among adults in B...
Charishma Pothireddy,Vignesh T P
Charishma Pothireddy
Infographic: impact of baseline visual acuity, time-in-range and early treatment on functional outcomes in DMO: insights from the IRISS outcomes [0.03%]
信息图：基线视力、时间范围和早期治疗对DME功能结局的影响：IRISS结果的启示
Igor Kozak,Ramin Khoramnia,Simon Taylor et al.
Igor Kozak et al.
A web of consequence: stellate fibrovascular proliferation heralding macular tractional retinal detachment in PDR [0.03%]
牵涉到视网膜脱离的糖尿病性黄斑星星状纤维血管增生
Samarth Kacker,Vignesh T P
Samarth Kacker
Infographic: Efficacy and Safety of HighDdose Intravitreal Aflibercept 8 mg in Patients with Treatment-Naïve Neovascular Age-Related Macular Degeneration: Week 96 Results from the Phase 3 PULSAR Trial [0.03%]
图表：高剂量8mg阿柏西普玻璃体内注射治疗新生血管性年龄相关性黄斑变性（nAMD）患者的疗效和安全性：III期PULSAR研究第96周结果
Jean-François Korobelnik,Sergio Leal,Paolo Lanzetta;PULSAR study investigators
Jean-François Korobelnik
Kemal Tekin,Seyfullah Ikbal Aksu,Mehmet Yasin Teke
Kemal Tekin
Clinical features and temporal trends in a large Japanese LHON cohort, 1995-2024: a retrospective study [0.03%]
1995-2024年日本LHON大样本病例的临床特征及时间趋势：一项回顾性研究
Yasuyuki Takai,Akiko Yamagami,Mayumi Iwasa et al.
Yasuyuki Takai et al.
Background/objectives: Leber hereditary optic neuropathy (LHON) exhibits population-specific characteristics in Japan, but long-term temporal changes remain unclear. ...
Devina Ramesh,Brendan K Tao,Cindy M L Hutnik
Devina Ramesh
Paraneoplastic uveal effusion secondary to metastatic gastric adenocarcinoma [0.03%]
胃腺癌转移所致的葡萄膜渗出症（伴发肿瘤性自身免疫反应）
Denis Nevrov,Susan Kennedy,Noel Horgan
Denis Nevrov
Infographic: Intravitreal aflibercept 8 mg in neovascular age-related macular degeneration (PULSAR): 48-week results from a randomised, double-masked, non-inferiority, Phase 3 trial [0.03%]
信息图：玻璃体内注射阿柏西普8mg治疗年龄相关性黄斑变性的新生血管（PULSAR）：一项随机、双盲、非劣效性III期试验的48周结果
Rivini Singappuli,Poorna Abeysiri,Waheeda Rahman
Rivini Singappuli